Clinique Neuro-Outaouais (CNO) - Multidisciplinary Neurology Treatment Center
Based in Gatineau, Quebec, and serving patients from across the Outaouais and Ottawa region, our multidisciplinary neurology treatment center helps people living with neurological disorders, such as multiple sclerosis (MS), Alzheimer’s disease (AD), Parkinson’s disease (PD), myasthenia gravis (MG), amyotrophic lateral sclerosis (ALS), and others.
Our team of experienced neurologists, nurses, and rehabilitation professionals works closely with patients in both clinical care and ongoing studies, bridging everyday neurological treatments with forward-looking research. Our goal is to achieve better outcomes by advancing new ways to understand, manage, and treat neurological conditions.
If you or someone close to you has a diagnosis that requires specialized neurological care, or would like to discuss participation in one of our clinical studies, book an appointment today to begin the process of assessment and care planning.
Our team of experienced neurologists, nurses, and rehabilitation professionals works closely with patients in both clinical care and ongoing studies, bridging everyday neurological treatments with forward-looking research. Our goal is to achieve better outcomes by advancing new ways to understand, manage, and treat neurological conditions.
If you or someone close to you has a diagnosis that requires specialized neurological care, or would like to discuss participation in one of our clinical studies, book an appointment today to begin the process of assessment and care planning.
Clinical Trials
Clinique Neuro-Outaouais, a center of excellence in clinical research, actively participates in numerous ongoing clinical trials involving various neurological diseases such as multiple sclerosis, myasthenia gravis, Parkinson’s disease etc. We are helping make the transition from the lab to the bedside for numerous medical discoveries. In the process we offer new therapeutic opportunities to people with chronic neurological conditions.
Help Us Make Wheelchairs Obsolete
NeuroGym® - Physical and Occupational Therapy for Neurologic Motor Impairments
NeuroGym® is a specialized rehabilitation centre built on more than two decades of research and clinical innovation in neurological recovery. Using patented tools and targeted therapy, we have created a “neurological gymnasium” where we help patients retrain movement, rebuild function, and restore independence.
Repetitive Transcranial Magnetic Stimulation (rTMS)
Repetitive transcranial magnetic stimulation, or rTMS, is a form of non-invasive neuromodulation whereby focal electrical currents induced by a magnetic pulse, done repetitively, can modulate over time how neuronal networks communicate within and between networks. The technique is effective in several psychiatric conditions such as medication resistant depression and PTSD. RTMS is also being explored in a variety of neurological conditions such as multiple sclerosis, Parkinson, Alzheimer’s and Glioblastoma Multiforme. Treatments are tailored to the individual and done under the supervision of a physician.
Infusion Clinic
Our infusion clinic provides intravenous and subcutaneous therapies in a calm, light-filled setting designed for comfort and safety. Treatments are overseen by medical specialists and administered by attentive, knowledgeable nurses who take a holistic approach to care. Each visit is an opportunity to rest, recharge, and receive treatment in a supportive environment.
Treatments include a variety of monoclonal antibodies used for different conditions such as multiple sclerosis, migraine, rheumatological disorders and cancer. On a case-by-case decision we can also administer intravenous antibiotics and corticosteroids. Please contact your prescribing physician if you would like to receive your therapy at our clinic.
News
We are proud to be setting new standards in neurological care across Canada. As a national first in multiple groundbreaking initiatives, our clinic has led the way in providing rapid access to innovative therapies and expanding treatment options for complex neurological conditions. From pioneering advanced migraine and Parkinson’s disease treatments to initiating novel Alzheimer’s therapies and introducing rTMS across a broad spectrum of neurological disorders, our commitment to innovation ensures patients receive timely, cutting-edge care in our clinic.
First in Canada
- To be designated as a clinic with rapid access to Vyepti (eptinezumab) for the treatment of migraine;
- To be designated as a starter clinic to initiate Vyalev (foslevodopa) for the treatment of Parkinson’s disease;
- First to initiate Leqembi(lecanumab) treatment in patients with Alzheimer’s disease;
- First to initiate Vyalev (foslevodopa) treatment in patients with Parkinson’s disease in a non university hospital setting;
- First to offer rTMS treatment for various neurological conditions : Alzheimer’s, ALS, Parkinson’s and Multiple Sclerosis.
Interested in our Clinical Trials?
Advancing clinical research is central to our mission. By participating in carefully designed studies, our patients gain access to emerging neurological treatments, often years before they become accessible to the general population.
Every study is conducted under the supervision of experienced clinicians, following rigorous ethical and medical standards.
Latest Blogs
New Theories of Disease Mechanisms in Secondary Progressive Multiple Sclerosis
Clear clinical, imaging, immunologic, or pathologic criteria marking the transition from relapsing disease to a progressive phase have not yet been firmly established, a reality
Disability Progression in Multiple Sclerosis; The Unmet Challenge
Multiple sclerosis (MS) is commonly seen as a chronic, inflammatory, demyelinating, and neurodegenerative progressive disease of the central nervous system (CNS). Primary progressive multiple sclerosis
Supply Issues and Cost of IVIG in Canada
Intravenous immunoglobulin (IVIG) is a therapy many people rely on for treatment for a variety of conditions, including myasthenia gravis (MG), and other autoimmune diseases,